2009's Information

2009/12/28

Notice for Large Volume Exercise of the 30th Round of Stock Options

2009/12/21

F647 New Drug Application (NDA) DRAFT In Review By Shanghai Food and Drug Administration

2009/12/07

Notice for Payment for Third-Party Allotment and the Issuance of the 30th Round of Stock Options

2009/11/20

GNI Announces Third-Party Allotment and the Issuance of the 30th Round of Stock Options.

2009/09/29

Schering-Plough Extends Joint Research Program with Shanghai Genomics

2009/09/29

The China Clinical Trials Outsourcing Congress

2009/09/10

Japan Biotech Forum: London 2009

2009/07/22

BioBusiness Asia 2009

2009/07/14

GNI Receives Important Patent Grants in China for Pirfenidone(F647) and in Australia for F351

2009/07/07

Notice of Exercise Price of Stock Option etc